48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection

NCT00089583 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Human Immunodeficiency Virus I

Interventions

DRUG: LEXIVA (GW433908)
DRUG: Ritonavir

Sponsor

ViiV Healthcare

Collaborators

[object Object]